Kalvista Pharmaceuticals
World Rank (Jan-05-2024)
13,685
Market Cap (Jan-05-2024)
0.419 Billion USD
World Rank (Jul-30-2023)
15,237
Market Cap (Jul-30-2023)
0.335 Billion USD
World Rank (Dec-25-2022)
20,435
Market Cap (Dec-25-2022)
0.126 Billion USD
World Rank (Jan-07-2022)
16,224
Market Cap (Jan-07-2022)
0.32 Billion USD
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-46 Million USD
Annual Results for Period Ending
Apr-2021 ending year
Company Profile
KalVista Pharmaceuticals is a Pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors as new treatments for diseases with significant unmet need. The company annual revenue is 12.7 million USD and 56 employees as on 2020. The headquarters is in USA.
Company Website